Meditrina Cyprus Plc

ISIN: CY0109701611 | Ticker: MEDTR | LEI: 213800TB7AYEE2DD5Y74

Sector: Health Care – Sub-Industry: Pharmaceuticals

Country: Cyprus

About Meditrina Cyprus Plc

Company Description

Meditrina Pharmaceuticals was founded in 2003 by a group of Pharmacists and experienced professionals in the pharmaceutical market.

In 2010 Meditrina Pharmaceuticals becomes part of Synapsis group of companies, a pharmaceutical group in Southern Eastern Europe with presence in Greece (Meditrina Pharmaceuticals Ltd), Cyprus (Synapsis Ltd), Romania (Solartium Group Srl), Bulgaria (Synapsis Bulgaria Ltd) and Moldova (Solartium Pharma Srl).

Meditrina Pharmaceuticals has offices in Athens and Thessaloniki and 31 employees. There are 4 sales units, covering every major area in the country, with 23 sales reps and 4 unit managers.

Year founded

2020

Served area

Cyprus + Greece

Headcount

Headquarters

Anexartisias 1 and Athinon 79, NORA Court, 2nd floor, 3040 Limassol – Cyprus

Filings & Publications

Insider Trades

Capital markets information

ISIN

CY0109701611

LEI

213800TB7AYEE2DD5Y74

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Cyprus Stock Exchange

Stock Index

CSE General Index

Contact Investor Relations department

First name*

Last name*

Your email*

Your phone number

Your company

Your message

I agree to the terms of the privacy policy.*

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.